What is he best known for?
The fields of study he is best known for:
- Major depressive disorder
- Internal medicine
- Psychiatry
Sanjay J. Mathew mostly deals with Anesthesia, Ketamine, Major depressive disorder, Antidepressant and Treatment-resistant depression.
He interconnects Endocrinology and Internal medicine in the investigation of issues within Anesthesia.
His research integrates issues of Randomized controlled trial and Esketamine in his study of Ketamine.
His Major depressive disorder research integrates issues from Endogenous depression and Tolerability.
His Antidepressant research is multidisciplinary, relying on both Pharmacotherapy, Mood disorders and Pharmacology.
His study explores the link between Treatment-resistant depression and topics such as Electroconvulsive therapy that cross with problems in Active placebo.
His most cited work include:
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial (642 citations)
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression (462 citations)
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression (451 citations)
What are the main themes of his work throughout his whole career to date?
Sanjay J. Mathew mainly investigates Ketamine, Internal medicine, Psychiatry, Anesthesia and Major depressive disorder.
His biological study spans a wide range of topics, including Randomized controlled trial, Midazolam and Antidepressant, Treatment-resistant depression, Depression.
His Internal medicine research is multidisciplinary, incorporating perspectives in Generalized anxiety disorder, Endocrinology and Oncology.
His work on Anxiety and Mood disorders as part of his general Psychiatry study is frequently connected to Suicidal ideation, Injury prevention and Suicide prevention, thereby bridging the divide between different branches of science.
His Intravenous ketamine study, which is part of a larger body of work in Anesthesia, is frequently linked to Lamotrigine, bridging the gap between disciplines.
His Major depressive disorder research includes themes of Clinical trial, Pathophysiology and Major depressive episode.
He most often published in these fields:
- Ketamine (45.45%)
- Internal medicine (37.73%)
- Psychiatry (31.82%)
What were the highlights of his more recent work (between 2018-2021)?
- Ketamine (45.45%)
- Treatment-resistant depression (28.18%)
- Internal medicine (37.73%)
In recent papers he was focusing on the following fields of study:
Sanjay J. Mathew mainly focuses on Ketamine, Treatment-resistant depression, Internal medicine, Antidepressant and Clinical trial.
Sanjay J. Mathew has researched Ketamine in several fields, including Psychotherapist, Midazolam, Mood disorders and Active placebo.
Many of his studies on Treatment-resistant depression involve topics that are commonly interrelated, such as Anesthesia.
His study on Intravenous ketamine is often connected to Blockade as part of broader study in Anesthesia.
Sanjay J. Mathew works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Anxiety disorder, as a part of the same area of interest.
His Antidepressant study combines topics from a wide range of disciplines, such as Major depressive disorder, Habenula and Naltrexone.
Between 2018 and 2021, his most popular works were:
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (97 citations)
- Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches (59 citations)
- A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia (33 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His scientific interests lie mostly in Treatment-resistant depression, Anesthesia, Ketamine, Anxiety and Internal medicine.
Treatment-resistant depression is a subfield of Major depressive disorder that Sanjay J. Mathew studies.
His Major depressive disorder study contributes to a more complete understanding of Psychiatry.
Sanjay J. Mathew combines topics linked to Depression with his work on Anesthesia.
His Ketamine study frequently involves adjacent topics like Midazolam.
His Anxiety research incorporates elements of Anhedonia and Mood.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
